Clinical TrialsSearch results
Number of results: 916
- Recruitment status
- Title of the study
- Health Condition
- Primary sponsor
- Date of registration
Other
- A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Trial Comparing the Efficacy and Safety of Tafasitamab Plus Lenalidomide in Addition to R-CHOP Versus R-CHOP in Previously Untreated, High-intermediate and High-risk Patients With Newly-diagnosed Diffuse Large B-cell Lymphoma (DLBCL)
- Diffuse Large B-cell Lymphoma
- Ueda Eiji
- 2022-06-24
Completed
- A Phase 3, Multicenter, Randomized, Double-Blinded, Placebo-Controlled Trial to Evaluate the Efficacy and the Safety of Efgartigimod (ARGX-113) PH20 Subcutaneous in Adult Patients With Primary Immune Thrombocytopenia
- Primary Immune Thrombocytopenia
- Gandini Domenica
- 2021-05-24
Completed
- A Phase 3, Randomized, Active-controlled, Observer-blinded, Non-inferiority Study to Evaluate the Safety and Immunogenicity of Booster Immunization with DS-5670a/b (Bivalent: Original Strain/Omicron Strain BA.4-5) in Subjects Aged 12 Years and Older Who Have Completed Initial and Booster Immunization with SARS-CoV-2 Vaccines
- Prevention of infection due to SARS-CoV-2
- Inoguchi Akihiro
- 2023-02-28
Other
- A Phase 3study of FF-31501 in meniscus tear patients
- Meniscus injuries indicated for meniscectomy
- Sakurai Tsutomu
- 2023-01-04
Completed
- A phase I clinical study of KSP-0243
- Healthy Condition
- Shimizu Yoshitaka
- 2021-01-20
Other
- A Phase I Clinical Study of NS-161 in Healthy Female Subjects
- Healthy volunteer
- Higashioka Masaya
- 2022-11-02
Recruiting
- A Phase I Clinical Study of NS-863 in Healthy Subjects
- Healthy volunteer
- Higashioka Masaya
- 2023-07-08
Completed
- A Phase I Dose Escalation and Food Effect Study of Isotretinoin
- Severe acne vulgaris
- Toida Tsuneyuki
- 2022-11-25
Other
- A Phase I Double-blind, Placebo-controlled Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AZD3152 in Healthy Japanese Adults
- COVID-19, SARS-CoV-2
- Ageishi Yuji
- 2023-07-12
Completed
- A PHASE I STUDY OF CASIRIVIMAB AND IMDEVIMAB IN JAPANESE ADULT VOLUNTEERS
- coronavirus disease 2019(COVID-19)
- Nanki Toshihiro
- 2021-03-29